These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8813351)

  • 21. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
    J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.
    Russo C; Angelini G; Dapino D; Piccini A; Piombo G; Schettini G; Chen S; Teller JK; Zaccheo D; Gambetti P; Tabaton M
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15598-602. PubMed ID: 9861015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
    Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
    Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
    J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
    Richey PL; Siedlak SL; Smith MA; Perry G
    Biochem Biophys Res Commun; 1995 Mar; 208(2):657-63. PubMed ID: 7695621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of apolipoprotein E in senile plaques in brains with Alzheimer's disease: investigation with the confocal laser scan microscope.
    Nishiyama E; Iwamoto N; Ohwada J; Arai H
    Brain Res; 1997 Mar; 750(1-2):20-4. PubMed ID: 9098525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microglial activation in Alzheimer disease: Association with APOE genotype.
    Egensperger R; Kösel S; von Eitzen U; Graeber MB
    Brain Pathol; 1998 Jul; 8(3):439-47. PubMed ID: 9669695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer's disease.
    Zhou W; Scott SA; Shelton SB; Crutcher KA
    Neuroscience; 2006 Dec; 143(3):689-701. PubMed ID: 16997486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease.
    Namba Y; Tsuchiya H; Ikeda K
    Neurosci Lett; 1992 Jan; 134(2):264-6. PubMed ID: 1375354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.
    Laws SM; Hone E; Taddei K; Harper C; Dean B; McClean C; Masters C; Lautenschlager N; Gandy SE; Martins RN
    Mol Psychiatry; 2002; 7(8):886-90. PubMed ID: 12232782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype.
    Montine KS; Reich E; Neely MD; Sidell KR; Olson SJ; Markesbery WR; Montine TJ
    J Neuropathol Exp Neurol; 1998 May; 57(5):415-25. PubMed ID: 9596412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
    Gomez-Isla T; West HL; Rebeck GW; Harr SD; Growdon JH; Locascio JJ; Perls TT; Lipsitz LA; Hyman BT
    Ann Neurol; 1996 Jan; 39(1):62-70. PubMed ID: 8572669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: a possible role for apolipoprotein E in Alzheimer's disease.
    Aizawa Y; Fukatsu R; Takamaru Y; Tsuzuki K; Chiba H; Kobayashi K; Fujii N; Takahata N
    Brain Res; 1997 Sep; 768(1-2):208-14. PubMed ID: 9369317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
    Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular lesions: a regional immunohistochemical study.
    Shao Y; Gearing M; Mirra SS
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):376-81. PubMed ID: 9100668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOE, vascular pathology, and the AD brain.
    Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
    Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E polymorphism and Alzheimer's disease.
    Poirier J; Davignon J; Bouthillier D; Kogan S; Bertrand P; Gauthier S
    Lancet; 1993 Sep; 342(8873):697-9. PubMed ID: 8103819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects.
    Yamaguchi H; Sugihara S; Ogawa A; Oshima N; Ihara Y
    J Neuropathol Exp Neurol; 2001 Jul; 60(7):731-9. PubMed ID: 11444802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain.
    Näslund J; Thyberg J; Tjernberg LO; Wernstedt C; Karlström AR; Bogdanovic N; Gandy SE; Lannfelt L; Terenius L; Nordstedt C
    Neuron; 1995 Jul; 15(1):219-28. PubMed ID: 7619525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.